Compare MBAI & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MBAI | UGRO |
|---|---|---|
| Founded | 2004 | 2014 |
| Country | Israel | United States |
| Employees | 85 | N/A |
| Industry | | Industrial Specialties |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0M | 13.2M |
| IPO Year | N/A | 2018 |
| Metric | MBAI | UGRO |
|---|---|---|
| Price | $1.76 | $4.59 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 151.3K | 93.2K |
| Earning Date | 05-12-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $17,399,438.00 |
| Revenue This Year | N/A | $462.72 |
| Revenue Next Year | N/A | $86.37 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.29 | $0.11 |
| 52 Week High | $3.92 | $39.68 |
| Indicator | MBAI | UGRO |
|---|---|---|
| Relative Strength Index (RSI) | 51.31 | 37.18 |
| Support Level | $1.35 | $0.28 |
| Resistance Level | $1.91 | $4.50 |
| Average True Range (ATR) | 0.18 | 0.64 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 45.70 | 18.23 |
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.
Urban-gro Inc operated as an integrated professional services and design-build firm offering architectural, engineering, and construction management solutions to the CEA, industrial, healthcare, and other commercial sectors. The company generated revenue by billing employees time on client projects and provided architectural, engineering, systems procurement and integration, and construction design-build solutions with a single point of accountability. For CEA clients, it developed indoor cultivation facilities for specialty crops, including cannabis and produce such as leafy greens, vegetables, herbs, and berries. Its segments included Equipment Systems (commercial horticulture equipment), Services (design-build services), and Construction Design-Build (general contracting).